PharmaCielo Ltd.
CVE: PCLO
|
|
| Canadian symbol: | PCLO.V |
| US symbol: | PCLOF |
| Market Cap (intraday) 5 | 76.08M |
| Enterprise Value 3 | 72.1M |
| Trailing P/E | N/A |
| Forward P/E 1 | 2.52 |
| PEG Ratio (5 yr expected) 1 | N/A |
| Price/Sales (ttm) | 58.46 |
| Price/Book (mrq) | 1.80 |
| Enterprise Value/Revenue 3 | 55.41 |
| Enterprise Value/EBITDA 6 | -2.21 |
| Beta (5Y Monthly) | N/A |
| 52-Week Change 3 | -88.38% |
| S&P500 52-Week Change 3 | 6.72% |
| 52 Week High 3 | 6.2800 |
| 52 Week Low 3 | 0.5000 |
| 50-Day Moving Average 3 | 0.8017 |
| 200-Day Moving Average 3 | 1.5543 |
| Avg Vol (3 month) 3 | 154.15k |
| Avg Vol (10 day) 3 | 109.92k |
| Shares Outstanding 5 | 111.88M |
| Float | 93.09M |
| % Held by Insiders 1 | 16.39% |
| % Held by Institutions 1 | 3.35% |
| Shares Short (Jun. 14, 2020) 4 | 1.22M |
| Short Ratio (Jun. 14, 2020) 4 | 15.54 |
| Short % of Float (Jun. 14, 2020) 4 | N/A |
| Short % of Shares Outstanding (Jun. 14, 2020) 4 | 3.63% |
| Shares Short (prior month May 14, 2020) 4 | 2.46M |
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | N/A |
| Trailing Annual Dividend Yield 3 | N/A |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:11 |
| Last Split Date 3 | Jan. 17, 2019 |
| Fiscal Year Ends | Dec. 30, 2019 |
| Most Recent Quarter (mrq) | Mar. 30, 2020 |
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -2,572.65% |
| Return on Assets (ttm) | -38.23% |
| Return on Equity (ttm) | -67.61% |
| Revenue (ttm) | 1.3M |
| Revenue Per Share (ttm) | 0.01 |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 643.48k |
| EBITDA | -32.56M |
| Net Income Avi to Common (ttm) | -33.25M |
| Diluted EPS (ttm) | -0.3410 |
| Quarterly Earnings Growth (yoy) | N/A |
| Total Cash (mrq) | 6.49M |
| Total Cash Per Share (mrq) | 0.06 |
| Total Debt (mrq) | 1.5M |
| Total Debt/Equity (mrq) | 4.01 |
| Current Ratio (mrq) | 2.59 |
| Book Value Per Share (mrq) | 0.38 |
| Operating Cash Flow (ttm) | -24.58M |
| Levered Free Cash Flow (ttm) | -21.66M |
| Company | News | Date | |
|---|---|---|---|
|
PCLO.V
PharmaCielo
|
|||
|
PCLO.V
PharmaCielo
|
1 month ago - cantechletter
cantechletter
|
||
|
PCLO.V
PharmaCielo
|
|||
|
PCLO.V
PharmaCielo
|
|||
|
PCLO.V
PharmaCielo
|
3 months ago - mugglehead
mugglehead
|
||
|
PCLO.V
PharmaCielo
|
3 months ago - investingnews
investingnews
|
||
|
PCLO.V
PharmaCielo
|
4 months ago - benzinga
benzinga
|
||
|
PCLO.V
PharmaCielo
|
|||
|
PCLO.V
PharmaCielo
|
5 months ago - thedeepdive
thedeepdive
|
||
|
PCLO.V
PharmaCielo
|
5 months ago - technical420
technical420
|
||
|
PCLO.V
PharmaCielo
|
|||
|
PCLO.V
PharmaCielo
|
|||
|
PCLO.V
PharmaCielo
|
7 months ago - finance
finance
|
||
|
PCLO.V
PharmaCielo
|
|||
|
PCLO.V
PharmaCielo
|
7 months ago - finance
finance
|
||
|
PCLO.V
PharmaCielo
|
|||
|
PCLO.V
PharmaCielo
|
8 months ago - investors
PharmaCielo Announces Termination of Scheme Implementation Agreement with Creso Pharma - Nov 5, 2019
investors
|
||
|
PCLO.V
PharmaCielo
|
8 months ago - investors
investors
|
||
|
PCLO.V
PharmaCielo
|
|||
|
PCLO.V
PharmaCielo
|
|||
|
PCLO.V
PharmaCielo
|
9 months ago - profitconfidential
profitconfidential
|
||
|
PCLO.V
PharmaCielo
|
10 months ago - cantechletter
cantechletter
|
||
|
PCLO.V
PharmaCielo
|
|||
|
PCLO.V
PharmaCielo
|
11 months ago - fool
fool
|
||
|
PCLO.V
PharmaCielo
|
11 months ago - mjbizdaily
mjbizdaily
|
||
|
PCLO.V
PharmaCielo
|
11 months ago - technical420
technical420
|
||
|
PCLO.V
PharmaCielo
|
|||
|
PCLO.V
PharmaCielo
|
|||
|
PCLO.V
PharmaCielo
|
1 year ago - cantechletter
cantechletter
|
||
|
PCLO.V
PharmaCielo
|
1 year ago - mjbizdaily
mjbizdaily
|
||
|
PCLO.V
PharmaCielo
|
|||
|
PCLO.V
PharmaCielo
|
|||
|
PCLO.V
PharmaCielo
|
1 year ago - cantechletter
cantechletter
|
||
|
PCLO.V
PharmaCielo
|
1 year ago - finance
PharmaCielo Establishes Joint Venture with Mino Labs to Bring Medicinal Cannabis Oil to Mexico
Joint Venture M&A
finance
|
||
|
PCLO.V
PharmaCielo
|
1 year ago - finance
finance
|
||
|
PCLO.V
PharmaCielo
|
|||
|
PCLO.V
PharmaCielo
|
1 year ago - finance
finance
|
||
|
PCLO.V
PharmaCielo
|
1 year ago - finance
finance
|
||
|
PCLO.V
PharmaCielo
|
1 year ago - finance
finance
|
||
|
PCLO.V
PharmaCielo
|
1 year ago - finance
finance
|
||
| Earnings Estimate | Current Qtr. (Jun 2020) | Next Qtr. (Sep 2020) | Current Year (2020) | Next Year (2021) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.08 | -0.07 | -0.29 | 0.27 |
| Low Estimate | -0.08 | -0.07 | -0.29 | 0.27 |
| High Estimate | -0.08 | -0.07 | -0.29 | 0.27 |
| Year Ago EPS | -0.11 | -0.04 | -0.33 | -0.29 |
| Revenue Estimate | Current Qtr. (Jun 2020) | Next Qtr. (Sep 2020) | Current Year (2020) | Next Year (2021) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 2 | 2 |
| Avg. Estimate | 140k | 1.65M | 25.61M | 94.49M |
| Low Estimate | 140k | 1.65M | 8.42M | 93.18M |
| High Estimate | 140k | 1.65M | 42.8M | 95.8M |
| Year Ago Sales | N/A | 130k | 787k | 25.61M |
| Sales Growth (year/est) | N/A | 1,169.20% | 3,154.10% | 269.00% |
| Earnings History | 2019-06-29 | 2019-09-29 | 2019-12-30 | 2020-03-30 |
|---|---|---|---|---|
| EPS Est. | -0.05 | -0.09 | -0.04 | -0.1 |
| EPS Actual | -0.11 | -0.04 | -0.13 | -0.07 |
| Difference | -0.06 | 0.05 | -0.09 | 0.03 |
| Surprise % | -120.00% | 55.60% | -225.00% | 30.00% |
| EPS Trend | Current Qtr. (Jun 2020) | Next Qtr. (Sep 2020) | Current Year (2020) | Next Year (2021) |
|---|---|---|---|---|
| Current Estimate | -0.08 | -0.07 | -0.29 | 0.27 |
| 7 Days Ago | -0.08 | -0.07 | -0.29 | 0.27 |
| 30 Days Ago | -0.06 | -0.05 | -0.21 | 0.2 |
| 60 Days Ago | 0 | 0 | -0.06 | 0.27 |
| 90 Days Ago | 0 | 0 | 0.52 | 0.21 |
| EPS Revisions | Current Qtr. (Jun 2020) | Next Qtr. (Sep 2020) | Current Year (2020) | Next Year (2021) |
|---|---|---|---|---|
| Up Last 7 Days | N/A | N/A | N/A | N/A |
| Up Last 30 Days | N/A | N/A | N/A | N/A |
| Down Last 7 Days | N/A | N/A | N/A | N/A |
| Down Last 30 Days | N/A | N/A | N/A | N/A |
| Growth Estimates | PCLO.V | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 27.30% | N/A | N/A | N/A |
| Next Qtr. | -75.00% | N/A | N/A | N/A |
| Current Year | 12.10% | N/A | N/A | N/A |
| Next Year | 193.10% | N/A | N/A | N/A |
| Next 5 Years (per annum) | N/A | N/A | N/A | N/A |
| Past 5 Years (per annum) | N/A | N/A | N/A | N/A |
| 16.39% | % of Shares Held by All Insider |
| 3.35% | % of Shares Held by Institutions |
| 4.01% | % of Float Held by Institutions |
| 7 | Number of Institutions Holding Shares |
| Holder | Shares | Date Reported | % Out | Value |
|---|---|---|---|---|
| Intercontinental Wealth Advisors, LLC | 12,500 | Dec. 30, 2019 | 0.01% | 38,125 |
| Symbol | Exchange | Price | Change | As of |
|---|---|---|---|---|
PCLO.V TSX Venture Exchange (former Canadian Ventures Exchange) | TSX Venture Exchange (former Canadian Ventures Exchange) | 0.68CAD | -- | |
PCLOF.PK OTC MARKETS GROUP L1 AND L2 | OTC MARKETS GROUP L1 AND L2 | 0.53USD | +8.16% | |
PCLO.GO Canadian Securities Exchange/PURE - CSE Listed & Other Canadian Listed Securities | Canadian Securities Exchange/PURE - CSE Listed & Other Canadian Listed Securities | 0.75CAD | 0.00% | |
PCLOF.PQ OTC MARKETS GROUP L1 AND L2 | OTC MARKETS GROUP L1 AND L2 | 0.53USD | +3.92% |
| Name | Age | Position | Appointed |
|---|---|---|---|
| Simon Anthony Christopher Langelier Chairman of the Board | -- | Chairman of the Board | -- |
| David Attard Chief Executive Officer, Director | -- | Chief Executive Officer, Director | -- |
| Scott Laitinen Chief Financial Officer | -- | Chief Financial Officer | -- |
| David Gordon Chief Corporate Officer | -- | Chief Corporate Officer | -- |
| Delon Human Global Head, Health and Innovation | -- | Global Head, Health and Innovation | -- |
| Douglas H. Bache Director | -- | Director | -- |
| Matteo Lorenzo Pellegrini Director | -- | Director | -- |
| Carlos Manuel Uribe Director | -- | Director | -- |
| Henning von Koss Director | -- | Director | -- |
